Among the types of uveitis, most of which are autoimmune diseases, through reducing the pro-inflammatory cytokines, IFN-γ+CD4+ cells, and IL-17+CD4+ cells, MSC-Exos can alleviate ocular inflammation (Zhang et al., 2021). This evidence concerns the gene CD4 and uveitis.